Low-cost, high-throughput DNA sequencing instruments and genomics platform
Ultima Genomics builds next-generation sequencing instruments aimed at cutting the cost of genomic data at scale. Its stack spans hardware design (Altium Designer, KiCad, PLM), bioinformatics pipelines (WDL, Nextflow, Snakemake) on AWS, GCP and Azure, and Salesforce plus NetSuite for revenue ops. Accelerating hiring balanced between engineering and sales, plus a Strategic Accounts Director search, points to a commercial push around instrument placements and lead-to-cash redesign.
Notable leadership hires: Strategic Accounts Director
Ultima Genomics is a privately held sequencing technology company founded in 2016 and headquartered in Fremont, California. It develops a new sequencing architecture intended to lower the cost of genomic information for scientists and clinicians. The company employs 201–500 people across engineering, research, manufacturing, sales and support functions. It hires in the United States and the United Arab Emirates.
Ultima Genomics uses Python, C++, Rust and Java, workflow tools like Nextflow, WDL, Snakemake, Airflow and Prefect, Docker and Kubernetes on AWS, GCP and Azure, plus Salesforce and NetSuite.
Yes. Hiring is accelerating across engineering, sales, manufacturing, research and support, including a Strategic Accounts Director role, in the United States and the United Arab Emirates.
Current work includes new product introductions, a field service development program, instrument placements, large sequencing projects, CRM automation and dashboards, and surface functionalization process development.
Other companies in the same industry, closest in size
Ultima Genomics's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.